Uncategorized

National Rapid Assessment Report on Institutional impact of COVID-19 among People of Color Community-Based Providers

For Immediate Release (ver versión en español abajo) Contact: Luis Scaccabarrozzi Lscaccabarozzi@latinoaids.org; Aaron Chandler AaronC@blackaids.org; Lance Toma lance@sfcommunityhealth.org National Rapid Assessment Report on Institutional impact of COVID-19 among People of Color Community-Based Providers New York, NY, February 22, 2020 - We are proud to release the Final Report of the National Rapid Assessment on the Institutional Impact of COVID-19 on Organizations Providing

National Hispanic/Latinx Health Leadership Network Releases Federal Health Policy Agenda “Our Health, Our Future”

New York, NY September 9, 2020—The National Hispanic/Latinx Health Leadership Network is proud to share the first ever community driven federal health policy agenda. The health policy agenda was finalized through a community participatory process in 2020, after close to two years of arduous work from over 200 organizations and

European Commission Grants Authorization for Gilead’s Veklury® (remdesivir) for Treatment of COVID-19

- Veklury is the First Approved Treatment Option for COVID-19 in the European Union -- FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted conditional marketing authorization for Veklury®(remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. The conditional marketing